Enzymotec

About

Enzymotec is a biotechnology company developing and manufacturing nutritional ingredients and medical foods.

Migdal Hameq,HaZafon,Israel
51 - 100

Highlights

Details

Last Funding Type: Series B
Last Funding Money Raised: $11M
Industries: Biotechnology,Health Care,Manufacturing
Founded date: Jan 1, 1998
Number Of Employee: 51 - 100
Operating Status: Active
Stock Symbol: nasdaq:ENZY

Enzymotec is a biotechnology company that develops and produces biofunctional ingredients to address health needs associated with the human life cycle, starting from babies up to seniors.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

5

$95.90M

Enzymotec has raised a total of $95.90M in funding over 2 rounds. Their latest funding was raised on Aug 1, 2017 from a Post-IPO Equity round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Aug 1, 2017	Post-IPO Equity	$12.90M	1	Frutarom	—	Detail
Sep 27, 2013	IPO	$62M	—	—	—	Detail
Jan 3, 2012	Series B	$10M	1	TPY Capital	—	Detail
Mar 21, 2010	Series Unknown	—	1	—	—	Detail
Feb 2, 2009	Series B	$11M	4	—	—	Detail

Investors

Number of Lead Investors

Number of Investors

2

7

Enzymotec is funded by 7 investors. Frutarom and TPY Capital are the most recent investors.

Investor Name	Lead Investor	Funding Round
Frutarom	Yes	Post-IPO Equity
TPY Capital	Yes	Series B
Vintage Investment Partners	—	Series Unknown
Millennium II Materials Technology Fund	—	Series B
Arancia International	—	Series B
Galam	—	Series B
Ofer Hi-Tech	—	Series B